Ally Financial’s Celgene Corp CELG Stock Holding History

Ally Financial’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,000	Closed	-$2.78M	–	131
2019 Q3	$2.78M	Hold	28,000	–	–	0.49%	62
2019 Q2	$2.59M	Hold	28,000	–	–	0.44%	61
2019 Q1	$2.64M	Hold	28,000	–	–	0.5%	65
2018 Q4	$1.79M	Hold	28,000	–	–	0.23%	83
2018 Q3	$2.5M	Buy	28,000 +8,000	+40%	+$707K	0.5%	65
2018 Q2	$1.59M	Hold	20,000	–	–	0.31%	83
2018 Q1	$1.78M	Hold	20,000	–	–	0.27%	89
2017 Q4	$2.09M	Buy	+20,000	New	+$2.26M	0.4%	68
2017 Q3	–	Sell	-20,000	Closed	-$2.6M	–	126
2017 Q2	$2.6M	Buy	+20,000	New	+$2.45M	0.51%	67
2016 Q4	–	Sell	-25,000	Closed	-$2.61M	–	126
2016 Q3	$2.61M	Hold	25,000	–	–	0.46%	59
2016 Q2	$2.47M	Hold	25,000	–	–	0.41%	78
2016 Q1	$2.5M	Buy	25,000 +17,000	+213%	+$1.75M	0.35%	89
2015 Q4	$958K	Buy	8,000 +1,000	+14%	+$116K	0.13%	117
2015 Q3	$757K	Sell	7,000 -15,000	-68%	-$1.86M	0.08%	136
2015 Q2	$2.55M	Buy	+22,000	New	+$2.52M	0.26%	91
2014 Q3	–	Sell	-44,000	Closed	-$3.78M	–	153
2014 Q2	$3.78M	Hold	44,000	–	–	0.44%	79
2014 Q1	$3.07M	Buy	+44,000	New	+$3.48M	0.33%	97

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Ally Financial's CELG Position: Q4 2019 in Review

Ally Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 28,000 shares — an estimated $2.78M sold.

Ally Financial first reported a position in CELG in Q1 2014 and held it in 17 quarters. The position peaked at $3.78M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Ally Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Ally Financial sold 28,000 Celgene Corp shares in Q4 2019, an estimated $2.78M.
Ally Financial first reported a position in Celgene Corp in Q1 2014 and held it in 17 quarters.
Ally Financial's Celgene Corp position peaked at $3.78M in Q2 2014.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ally Financial's 13F filing for Q4 2019, filed 13 Feb 2020.